IsoBio
IsoBio is a US startup, founded in 2025. It has raised at least $1.7m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
IsoBio has raised at least $1.7m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
Related
Questions and answers
What does IsoBio do?
IsoBio is classed in healthcare in its filings with the US Securities and Exchange Commission.
How much has IsoBio raised?
At least $1.7m, according to its Form D filings with the US Securities and Exchange Commission.
Where is IsoBio based?
IsoBio is registered in United States; its operating headquarters is not yet confirmed.
When was IsoBio founded?
IsoBio was founded in 2025.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.